Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Akero Therapeutics Inc (NASDAQ: AKRO) was $28.15 for the day, up 5.23% from the previous closing price of $26.75. In other words, the price has increased by $5.23 from its previous closing price. On the day, 0.45 million shares were traded. AKRO stock price reached its highest trading level at $28.9703 during the session, while it also had its lowest trading level at $26.94.
Ratios:
Our analysis of AKRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 24.89 and its Current Ratio is at 24.89. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.UBS initiated its Buy rating on August 28, 2023, with a $83 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 01 ’24 when Young Jonathan sold 10,000 shares for $28.18 per share. The transaction valued at 281,770 led to the insider holds 226,286 shares of the business.
Jonathan Young bought 110,716 shares of AKRO for $3,156,513 on Oct 01 ’24. On Sep 20 ’24, another insider, Yale Catriona, who serves as the Chief Development Officer of the company, sold 5,500 shares for $27.65 each. As a result, the insider received 152,086 and left with 75,294 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1954477056 and an Enterprise Value of 1230194688.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $50.29, while it has fallen to a 52-week low of $11.25. The 50-Day Moving Average of the stock is 6.04%, while the 200-Day Moving Average is calculated to be 17.52%.
Shares Statistics:
AKRO traded an average of 576.87K shares per day over the past three months and 537210 shares per day over the past ten days. A total of 69.43M shares are outstanding, with a floating share count of 58.10M. Insiders hold about 16.32% of the company’s shares, while institutions hold 98.58% stake in the company. Shares short for AKRO as of 1726185600 were 7163232 with a Short Ratio of 12.42, compared to 1723680000 on 7193443. Therefore, it implies a Short% of Shares Outstanding of 7163232 and a Short% of Float of 10.620000000000001.
